Adventist Health Portland, is a 302-bed hospital serving 900,000 residents on the east side of the Portland-Vancouver metropolitan area in the United States. It is the primary teaching hospital of the Walla Walla University Nursing program.

There are 302 beds in Adventist Medical Center.

During the past decade, Adventist Medical Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 47 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Adventist Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 26 trials, followed by "SWOG Cancer Research Network" with 18 trials sponsored, "Alliance for Clinical Trials in Oncology" with 15 trials sponsored, "Radiation Therapy Oncology Group" with 3 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Adventist Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 39 trials as a collaborator, "Cancer and Leukemia Group B" with 8 trials as a collaborator, "Eastern Cooperative Oncology Group" with 6 trials as a collaborator, "NCIC Clinical Trials Group" with 6 trials as a collaborator and "SWOG Cancer Research Network" with 5 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Adventist Medical Center" are "Breast Cancer" (10 trials), "Lymphoma" (9 trials), "Lung Cancer" (6 trials), "Recurrent Breast Carcinoma" (4 trials) and "Unspecified Adult Solid Tumor, Protocol Specific" (4 trials). Many other conditions were trialed in "Adventist Medical Center" in a lesser frequency.

Most popular intervention types in "Adventist Medical Center" are "Drug" (52 trials), "Other" (32 trials), "Biological" (26 trials), "Radiation" (7 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (12 trials), "Laboratory Biomarker Analysis" (12 trials), "placebo" (8 trials), "Quality-of-Life Assessment" (5 trials) and "bevacizumab" (5 trials). Other intervention names were less common.

The vast majority of trials in "Adventist Medical Center" are 53 trials for "All" genders, 11 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Adventist Medical Center". undefined are not yet recruiting, undefined are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 43 completed trials in Adventist Medical Center, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Adventist Medical Center, 0 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".